MDXG FY 2021 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$684M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$242M-2.5% YoY

Gross Profit

$202M83.6% margin

Operating Income

-$7M-2.9% margin

Net Income

-$12M-5.1% margin

EPS (Diluted)

$-0.09

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$5M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$188M

Total Liabilities

$95M

Stockholders' Equity

$93M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$242M	$248M	-2.5%
Gross Profit	$202M	$209M	-3.1%
Operating Income	-$7M	-$45M	+84.5%
Net Income	-$12M	-$49M	+75.0%